世界のスーパージェネリック市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Super Generics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4915 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、スーパージェネリックの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・スーパージェネリックの市場動向 ・企業の競争状況、市場シェア ・スーパージェネリックの種類別市場規模と予測2016-2027（経口、注射、その他） ・スーパージェネリックの用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・スーパージェネリックの北米市場規模2016-2027（アメリカ、カナダ） ・スーパージェネリックの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・スーパージェネリックのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・スーパージェネリックの中南米市場規模2016-2027（メキシコ、ブラジル） ・スーパージェネリックの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sun Pharmaceutical Industries、Meda Pharmaceuticals、Taiwan Liposome Company、Dr. Reddy’s Laboratories、Allergan、Teva Pharmaceutical、Celgene Corporation） ・結論

The huge cost of drug development and the time overruns to develop new therapeutics have hindered innovation in the drug research and development space by promoting companies to find alternatives to maintain patent protection for a given brand. Super generics or modified therapeutic entities are an excellent form of a given generic drug molecule, which has better patient compliance and therapeutic effect than existing generic drugs.

Market Analysis and Insights: Global Super Generics Market
The global Super Generics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Super Generics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Super Generics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Super Generics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Super Generics market.

Global Super Generics Scope and Market Size
Super Generics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Super Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injectable
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sun Pharmaceutical Industries
Meda Pharmaceuticals
Taiwan Liposome Company
Dr. Reddy’s Laboratories
Allergan
Teva Pharmaceutical
Celgene Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Super Generics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injectable
1.2.4 Others
1.3 Market by Application
1.3.1 Global Super Generics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Super Generics Market Perspective (2016-2027)
2.2 Super Generics Growth Trends by Regions
2.2.1 Super Generics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Super Generics Historic Market Share by Regions (2016-2021)
2.2.3 Super Generics Forecasted Market Size by Regions (2022-2027)
2.3 Super Generics Industry Dynamic
2.3.1 Super Generics Market Trends
2.3.2 Super Generics Market Drivers
2.3.3 Super Generics Market Challenges
2.3.4 Super Generics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Super Generics Players by Revenue
3.1.1 Global Top Super Generics Players by Revenue (2016-2021)
3.1.2 Global Super Generics Revenue Market Share by Players (2016-2021)
3.2 Global Super Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Super Generics Revenue
3.4 Global Super Generics Market Concentration Ratio
3.4.1 Global Super Generics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Super Generics Revenue in 2020
3.5 Super Generics Key Players Head office and Area Served
3.6 Key Players Super Generics Product Solution and Service
3.7 Date of Enter into Super Generics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Super Generics Breakdown Data by Type
4.1 Global Super Generics Historic Market Size by Type (2016-2021)
4.2 Global Super Generics Forecasted Market Size by Type (2022-2027)

5 Super Generics Breakdown Data by Application
5.1 Global Super Generics Historic Market Size by Application (2016-2021)
5.2 Global Super Generics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Super Generics Market Size (2016-2027)
6.2 North America Super Generics Market Size by Type
6.2.1 North America Super Generics Market Size by Type (2016-2021)
6.2.2 North America Super Generics Market Size by Type (2022-2027)
6.2.3 North America Super Generics Market Size by Type (2016-2027)
6.3 North America Super Generics Market Size by Application
6.3.1 North America Super Generics Market Size by Application (2016-2021)
6.3.2 North America Super Generics Market Size by Application (2022-2027)
6.3.3 North America Super Generics Market Size by Application (2016-2027)
6.4 North America Super Generics Market Size by Country
6.4.1 North America Super Generics Market Size by Country (2016-2021)
6.4.2 North America Super Generics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Super Generics Market Size (2016-2027)
7.2 Europe Super Generics Market Size by Type
7.2.1 Europe Super Generics Market Size by Type (2016-2021)
7.2.2 Europe Super Generics Market Size by Type (2022-2027)
7.2.3 Europe Super Generics Market Size by Type (2016-2027)
7.3 Europe Super Generics Market Size by Application
7.3.1 Europe Super Generics Market Size by Application (2016-2021)
7.3.2 Europe Super Generics Market Size by Application (2022-2027)
7.3.3 Europe Super Generics Market Size by Application (2016-2027)
7.4 Europe Super Generics Market Size by Country
7.4.1 Europe Super Generics Market Size by Country (2016-2021)
7.4.2 Europe Super Generics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Super Generics Market Size (2016-2027)
8.2 Asia-Pacific Super Generics Market Size by Type
8.2.1 Asia-Pacific Super Generics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Super Generics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Super Generics Market Size by Type (2016-2027)
8.3 Asia-Pacific Super Generics Market Size by Application
8.3.1 Asia-Pacific Super Generics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Super Generics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Super Generics Market Size by Application (2016-2027)
8.4 Asia-Pacific Super Generics Market Size by Region
8.4.1 Asia-Pacific Super Generics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Super Generics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Super Generics Market Size (2016-2027)
9.2 Latin America Super Generics Market Size by Type
9.2.1 Latin America Super Generics Market Size by Type (2016-2021)
9.2.2 Latin America Super Generics Market Size by Type (2022-2027)
9.2.3 Latin America Super Generics Market Size by Type (2016-2027)
9.3 Latin America Super Generics Market Size by Application
9.3.1 Latin America Super Generics Market Size by Application (2016-2021)
9.3.2 Latin America Super Generics Market Size by Application (2022-2027)
9.3.3 Latin America Super Generics Market Size by Application (2016-2027)
9.4 Latin America Super Generics Market Size by Country
9.4.1 Latin America Super Generics Market Size by Country (2016-2021)
9.4.2 Latin America Super Generics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Super Generics Market Size (2016-2027)
10.2 Middle East & Africa Super Generics Market Size by Type
10.2.1 Middle East & Africa Super Generics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Super Generics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Super Generics Market Size by Type (2016-2027)
10.3 Middle East & Africa Super Generics Market Size by Application
10.3.1 Middle East & Africa Super Generics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Super Generics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Super Generics Market Size by Application (2016-2027)
10.4 Middle East & Africa Super Generics Market Size by Country
10.4.1 Middle East & Africa Super Generics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Super Generics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sun Pharmaceutical Industries
11.1.1 Sun Pharmaceutical Industries Company Details
11.1.2 Sun Pharmaceutical Industries Business Overview
11.1.3 Sun Pharmaceutical Industries Super Generics Introduction
11.1.4 Sun Pharmaceutical Industries Revenue in Super Generics Business (2016-2021)
11.1.5 Sun Pharmaceutical Industries Recent Development
11.2 Meda Pharmaceuticals
11.2.1 Meda Pharmaceuticals Company Details
11.2.2 Meda Pharmaceuticals Business Overview
11.2.3 Meda Pharmaceuticals Super Generics Introduction
11.2.4 Meda Pharmaceuticals Revenue in Super Generics Business (2016-2021)
11.2.5 Meda Pharmaceuticals Recent Development
11.3 Taiwan Liposome Company
11.3.1 Taiwan Liposome Company Company Details
11.3.2 Taiwan Liposome Company Business Overview
11.3.3 Taiwan Liposome Company Super Generics Introduction
11.3.4 Taiwan Liposome Company Revenue in Super Generics Business (2016-2021)
11.3.5 Taiwan Liposome Company Recent Development
11.4 Dr. Reddy’s Laboratories
11.4.1 Dr. Reddy’s Laboratories Company Details
11.4.2 Dr. Reddy’s Laboratories Business Overview
11.4.3 Dr. Reddy’s Laboratories Super Generics Introduction
11.4.4 Dr. Reddy’s Laboratories Revenue in Super Generics Business (2016-2021)
11.4.5 Dr. Reddy’s Laboratories Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Super Generics Introduction
11.5.4 Allergan Revenue in Super Generics Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Super Generics Introduction
11.6.4 Teva Pharmaceutical Revenue in Super Generics Business (2016-2021)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Super Generics Introduction
11.7.4 Celgene Corporation Revenue in Super Generics Business (2016-2021)
11.7.5 Celgene Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Super Generics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of Others
Table 5. Global Super Generics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Super Generics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Super Generics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Super Generics Market Share by Regions (2016-2021)
Table 9. Global Super Generics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Super Generics Market Share by Regions (2022-2027)
Table 11. Super Generics Market Trends
Table 12. Super Generics Market Drivers
Table 13. Super Generics Market Challenges
Table 14. Super Generics Market Restraints
Table 15. Global Super Generics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Super Generics Market Share by Players (2016-2021)
Table 17. Global Top Super Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Super Generics as of 2020)
Table 18. Ranking of Global Top Super Generics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Super Generics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Super Generics Product Solution and Service
Table 22. Date of Enter into Super Generics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Super Generics Revenue Market Share by Type (2016-2021)
Table 26. Global Super Generics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Super Generics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Super Generics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Super Generics Revenue Market Share by Application (2016-2021)
Table 30. Global Super Generics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Super Generics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Super Generics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Super Generics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Super Generics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Super Generics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Super Generics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Super Generics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Super Generics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Super Generics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Super Generics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Super Generics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Super Generics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Super Generics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Super Generics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Super Generics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Super Generics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Super Generics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Super Generics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Super Generics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Super Generics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Super Generics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Super Generics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Super Generics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Super Generics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Super Generics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Super Generics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Super Generics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sun Pharmaceutical Industries Company Details
Table 63. Sun Pharmaceutical Industries Business Overview
Table 64. Sun Pharmaceutical Industries Super Generics Product
Table 65. Sun Pharmaceutical Industries Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 66. Sun Pharmaceutical Industries Recent Development
Table 67. Meda Pharmaceuticals Company Details
Table 68. Meda Pharmaceuticals Business Overview
Table 69. Meda Pharmaceuticals Super Generics Product
Table 70. Meda Pharmaceuticals Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 71. Meda Pharmaceuticals Recent Development
Table 72. Taiwan Liposome Company Company Details
Table 73. Taiwan Liposome Company Business Overview
Table 74. Taiwan Liposome Company Super Generics Product
Table 75. Taiwan Liposome Company Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 76. Taiwan Liposome Company Recent Development
Table 77. Dr. Reddy’s Laboratories Company Details
Table 78. Dr. Reddy’s Laboratories Business Overview
Table 79. Dr. Reddy’s Laboratories Super Generics Product
Table 80. Dr. Reddy’s Laboratories Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 81. Dr. Reddy’s Laboratories Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Super Generics Product
Table 85. Allergan Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Teva Pharmaceutical Company Details
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Super Generics Product
Table 90. Teva Pharmaceutical Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceutical Recent Development
Table 92. Celgene Corporation Company Details
Table 93. Celgene Corporation Business Overview
Table 94. Celgene Corporation Super Generics Product
Table 95. Celgene Corporation Revenue in Super Generics Business (2016-2021) & (US$ Million)
Table 96. Celgene Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Super Generics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Others Features
Figure 5. Global Super Generics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Super Generics Report Years Considered
Figure 10. Global Super Generics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Super Generics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Super Generics Market Share by Regions: 2020 VS 2027
Figure 13. Global Super Generics Market Share by Regions (2022-2027)
Figure 14. Global Super Generics Market Share by Players in 2020
Figure 15. Global Top Super Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Super Generics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Super Generics Revenue in 2020
Figure 17. Global Super Generics Revenue Market Share by Type (2016-2021)
Figure 18. Global Super Generics Revenue Market Share by Type (2022-2027)
Figure 19. North America Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Super Generics Market Share by Type (2016-2027)
Figure 21. North America Super Generics Market Share by Application (2016-2027)
Figure 22. North America Super Generics Market Share by Country (2016-2027)
Figure 23. United States Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Super Generics Market Share by Type (2016-2027)
Figure 27. Europe Super Generics Market Share by Application (2016-2027)
Figure 28. Europe Super Generics Market Share by Country (2016-2027)
Figure 29. Germany Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Super Generics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Super Generics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Super Generics Market Share by Region (2016-2027)
Figure 39. China Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Super Generics Market Share by Type (2016-2027)
Figure 47. Latin America Super Generics Market Share by Application (2016-2027)
Figure 48. Latin America Super Generics Market Share by Country (2016-2027)
Figure 49. Mexico Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Super Generics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Super Generics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Super Generics Market Share by Country (2016-2027)
Figure 55. Turkey Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Super Generics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sun Pharmaceutical Industries Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 59. Meda Pharmaceuticals Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 60. Taiwan Liposome Company Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 61. Dr. Reddy’s Laboratories Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 62. Allergan Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 64. Celgene Corporation Revenue Growth Rate in Super Generics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---